In a bid to reshape Pfizer’s future, activist investor Starboard Value has acquired a stake worth approximately $1 billion, ...

Elon Musk appeared onstage at a rally for the former president this weekend, but Silicon Valley was abuzz about Ben ...

Pfizer shares rise on report of activist investor stake, ExxonMobil stock adds to record highs as oil prices continue surge, ...

Pfizer’s CEO reflects on a year of discovery and what he thinks critics get wrong about vaccine pricing Albert Bourla talks about his employees' effort to develop a COVID-19 vaccine in record ...

Albert Bourla could be seen saying ... But the clip had been taken out of context from a longer interview, with Yahoo Finance, in which Mr Bourla had been discussing high infection rates with ...

With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.

A top EU court said Monday that it would hear a lawsuit next month over the release of private text messages that European Commission chief Ursula von der Leyen sent to negotiate Covid vaccine ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Pfizer chief executive Albert Bourla said in an interview the progress was slower than he had hoped because "few countries are really mobilising themselves to bring the products in". Ten countries ...

The U.S. Department of Justice is considering asking a judge to force Google to sell parts of its business to mitigate its ...

Friday’s announcement represents a shift in tone for the company and its leader, who has repeatedly emphasized the month of October in interviews ... Dr. Albert Bourla, said the drug-making ...

Albert Bourla said Pfizer expects to price its treatment, called Paxlovid, close to where rival Merck & Co Inc has priced its oral antiviral drug candidate. The companies said the vaccine ...